Search
Nov. 28, 2022, New York, NY — Nephrologist and researcher Susan Hedayati, MD, MHSc, will be honored by the National Kidney Foundation (NKF) with the prestigious Shaul G. Massry Distinguished Lecture at one of the nation’s most regarded gatherings of kidney professionals in 2023 for her discoveries in kidney disease.
Each year NKF considers the work of hundreds of specialists in the field of Nephrology and selects among...
October 19, 2022, New York, NY — The National Kidney Foundation (NKF) is proud to announce the renewed appointment of board member Sam Marchio as the Secretary to its national Board of Directors. The re-elected member was nominated and approved at NKF’s most recent board meeting held earlier this month.
“Sam has been an outstanding...
(December 20, 2022, New York, NY) — The National Kidney Foundation (NKF) Innovation Fund, the philanthropic impact investment program of NKF, has made its latest investment in MediGO Inc., a first-of-its-kind healthcare supply chain technology company focused on improving equity, access, and transparency in the organ...
(April 13, 2023, New York, NY) —Lilia Cervantes, MD, a healthcare advocate in communities of undocumented immigrants, was the keynote speaker at the National Kidney Foundation’s (NKF) Spring Clinical Meetings held in Austin, TX from April 11th thru 15th.
Dr. Cervantes is an associate professor at the University of Colorado Anschutz Medical Campus...
(April 14, 2022, AUSTIN, TX) —The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the results of the trial are not final, they offer valuable information for patients using the generic drug Spironolactone. This drug therapy activates white cells and...
(April 12, 2023, New York, NY) — The National Kidney Foundation (NKF) will feature a late-breaking plenary session by Travere Therapeutics on the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) in adults with IgA nephropathy (IgAN). “Rapid and Sustained Proteinuria Reduction with Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results...
November 11, 2022, New York, NY — The following is a statement from Kevin Longino, Chief Executive Officer of the National Kidney Foundation and a kidney transplant recipient on media reports of organ transplant system failures
“Media reports this morning about Congress’ investigation into the organ...
Statement from the National Kidney Foundation on today’s news on the organ transplant system
March 22, 2023, New York, NY — The following statement is from Kevin Longino, Chief Executive Officer and kidney transplant recipient, regarding today’s announcement from the Health Resources and Services Administration (HRSA) about its plan to overhaul the organ transplant system.
“The National Kidney Foundation (NKF)...
(March 20, 2023, New York, NY) — The National Kidney Foundation (NKF) will present the 2023 Joel D. Kopple Award to Kentucky renal dietitian Lois Hill, MS, RDN, LD, LDE, for her significant contributions to the field of renal nutrition. The award is in the name of the “father of renal nutrition” and will be presented at the...